GLP1R and Hypoglycemia: In a parallel‐design RCT, 72‐hour infusion of GLP‐1 did not reduce intravenous insulin requirement nor the rate of hypoglycaemia compared with saline control, although there was less plasma glucose variability with GLP‐1.